Pricing Log in Create free account

KALA BIO, Inc. (KALA) vs 60 Degrees Pharmaceuticals Inc. (SXTP)

KALA BIO, Inc. and 60 Degrees Pharmaceuticals Inc. are both Biotechnology companies. KALA BIO, Inc. and 60 Degrees Pharmaceuticals Inc. are of similar size ($3.2M and $3.0M). 60 Degrees Pharmaceuticals Inc. grew revenue faster over the last twelve months: 23.4% against −50.5%. KALA BIO, Inc. has the higher net margin (0.00% vs −678.0%) and the lower return on invested capital (−722.7% vs −348.6%). Across the 15 metrics below, 60 Degrees Pharmaceuticals Inc. leads on 8 and KALA BIO, Inc. on 7.

Valuation

Metric KALA SXTP Biotechnology median
P/E n/m n/m 10.60
P/S 0.52 1.31 9.40
P/B 0.33 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 8.04 1.47 9.02
Earnings yield (31,890.31%) (1,046.67%) (32.88%)
Free cash flow yield (667.16%) (569.15%) (23.13%)

Profitability

Metric KALA SXTP Biotechnology median
Gross margin 0.00% 43.42% 68.51%
Operating margin 0.00% (691.33%) 0.00%
Net margin 0.00% (678.03%) 0.00%
Free cash flow margin 0.00% (745.93%) 0.00%
Return on equity (345.32%) 115.54% (51.96%)
Return on assets (43.23%) (194.65%) (46.06%)
Return on invested capital (722.69%) (348.64%) 0.00%

Growth

Metric KALA SXTP Biotechnology median
Revenue growth (TTM) (50.54%) 23.41% 6.76%
EPS growth (last fiscal year) 67.39% 84.19% 29.88%
Revenue growth, 5-year CAGR — (11.18%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KALA SXTP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.88 2.32 4.97
Net debt to EBITDA 0.19 0.37 1.01

Dividend

Metric KALA SXTP Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KALA SXTP Biotechnology median
Market cap 2.95m 3.22m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack